go back

Can Racial, Social, and Gender Bias Affect the Treatment of People with Dementia?

Marco Aurélio Gomes Veado

4 min read

March 3, 2026

Listen to audio version of this article

0:00

0:00

Dementia does not discriminate, but healthcare systems sometimes do.

Across the world, millions of people live with Alzheimer’s disease and other forms of cognitive decline. Yet growing research suggests that racial, social, and gender bias may influence how dementia is diagnosed, treated, and managed.

This raises an urgent ethical and medical question:

Are some people receiving less accurate diagnoses, delayed treatment, or inadequate care simply because of who they are?

Image generated by AI CANVA

Diagnostic Delays and Underdiagnosis

Studies show that minority populations are often diagnosed later in the disease process. In the United States, for example, African American and Hispanic individuals are more likely to develop dementia.

Still, they are less likely to receive an early and accurate diagnosis compared to white patients.

Language barriers, cultural differences, limited access to specialists, and implicit bias in clinical assessments all play a role. Cognitive tests were historically standardized using predominantly white, educated populations, which may skew results when applied across diverse communities.

The result? Underdiagnosis in some groups, overdiagnosis in others, and missed opportunities for early intervention.

Gender Bias in Dementia Care

Women represent nearly two-thirds of people living with Alzheimer’s disease. Biological factors partly explain this, including longevity and possible hormonal influences. However, gender bias may also affect diagnosis and care.

Memory complaints in women are sometimes dismissed as stress, depression, or emotional overload (particularly in midlife).

Conversely, cognitive decline in men may be under-recognized because men are less likely to report early symptoms or seek medical evaluation.

In addition, women are more likely to serve as caregivers, often unpaid and unsupported, which compounds the emotional and economic burden of dementia within families.

Socioeconomic Inequality and Access to Care

Socioeconomic status strongly influences dementia outcomes. Individuals from lower-income communities frequently face:

  • Reduced access to neurologists and memory clinics
  • Limited availability of diagnostic imaging
  • Financial barriers to medication
  • Lower health literacy

Chronic stress, reduced educational opportunities, poor nutrition, and limited preventive healthcare also increase dementia risk across the lifespan.

In countries with deep structural inequality, these factors intersect. Racial minorities are disproportionately represented in lower-income communities, amplifying disparities.

Implicit Bias in Clinical Settings

Implicit bias refers to unconscious attitudes or stereotypes that affect decisions.

Even well-intentioned healthcare professionals may unknowingly interpret symptoms differently depending on a patient’s race, gender, or socioeconomic background.

For example:

  • Behavioral symptoms in minority patients may be misattributed to psychiatric conditions rather than neurodegeneration.
  • Pain and discomfort may be underestimated in certain populations.
  • Family concerns may be dismissed more readily in marginalized groups.

These subtle patterns accumulate over time and can significantly affect clinical outcomes.

Why Equity in Dementia Care Matters

Early diagnosis allows for:

  • Better symptom management
  • Lifestyle interventions
  • Participation in clinical trials
  • Advance care planning

When bias delays diagnosis or limits access to care, patients lose valuable time, and families lose critical support.

Equitable dementia care is not simply a matter of fairness; it is a public health necessity.

Moving Toward Inclusive Care

Addressing bias requires systemic and individual change:

  • Diversifying research populations
  • Adapting cognitive assessments for cultural fairness
  • Expanding access to memory clinics in underserved areas
  • Training healthcare professionals in cultural competence
  • Supporting caregivers across all communities

Organizations such as the World Health Organization and the Alzheimer's Association have emphasized the importance of equity in dementia strategies.

But real change depends on awareness, and on challenging long-standing assumptions about who is at risk and who deserves access to care.

Conclusion

Dementia is a neurological condition. But treatment outcomes are shaped by social structures.

If we are serious about reducing the global burden of cognitive decline, we must confront the reality that bias, whether racial, social, or gender-based, can influence who is heard, who is believed, and who receives timely care.

Equity is not optional in dementia care. It is essential.

Share and sign up for our bi-weekly newsletter, featuring important resources and information for caregivers of individuals with dementia and mild cognitive impairment. MCI and Beyond.

References

  1. Alzheimer's Association. 2023 Alzheimer’s Disease Facts and Figures.
  2. World Health Organization. Global status report on the public health response to dementia.
  3. Barnes LL et al. Racial differences in the association between education and dementia risk. Neurology.
  4. Mayeda ER et al. Inequalities in dementia incidence between six racial and ethnic groups. Alzheimer’s & Dementia.
  5. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.

#DementiaCare #HealthEquity #AlzheimersAwareness #CognitiveHealth #InclusiveHealthcare #PublicHealth #BrainHealth #MCIandBeyond #CaregiverSupport #Neuroethics

Sign up for our newsletter!

Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.

MCI and Beyond
AboutBlogContactFAQ
YouTubeTwitterFacebookInstagramLinkedIn

© 2026 MCI and Beyond. All rights reserved.